Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Meds India LTD
WARNING LETTER
•Meds India LTD

Meds India LTD – FDA Warning Letter

Record Details

The FDA issued a Warning Letter after reviewing numerous websites offering unapproved new drugs and misbranded drugs for sale, violating sections 301(a), 301(d), 502(f), 503(b), and 505(a) of the FD&C Act.

The violations include selling unapproved new drugs like "Generic Nolvadex" (for breast cancer) and "Generic Meridia" (for obesity). "Generic Nolvadex" lacks an FDA-approved application and the required black box warning for serious adverse events, unlike its approved counterparts. "Generic Meridia" is an unapproved new drug, as the brand-name Meridia was withdrawn from the U.S. market in 2010 due to increased risks of heart attack and stroke.

Additionally, the websites offer misbranded prescription drugs such as "Generic Valium" and "Generic Xanax" without requiring a prescription, despite being controlled substances with abuse potential and requiring licensed practitioner supervision. These products also lack adequate directions for use. Unapproved Accutane (isotretinoin) is also sold, which was withdrawn from the market in 2010. Furthermore, isotretinoin products are misbranded as they bypass the FDA's restricted distribution REMS program (iPLEDGE), which is crucial for preventing fetal exposure and informing users of serious risks.

The FDA requires immediate cessation of marketing these viol

Company
Meds India LTD
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Thomas (TJ) Christl (Office Director)
View Company Profile

ID · 4ba4f3fc-64f2-414e-a9ba-53420f1a8bb0

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 321(p)21 U.S.C. 331(d)21 U.S.C. 352(f)21 U.S.C. 353(b)21.U.S.C. 355(a)21 U.S.C. 353(b)(1)(A)21 U.S.C. 353(b)(1)(B)(i)21 U.S.C. 353(b)(1)(B)(iii)21 U.S.C. 352(f)(1)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Meds India LTD
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.